Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices (Q28295533)

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Europe PubMed Central

title

Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices (English)

0 references

1 reference

1 reference

1 reference

Martin Miner

1

0 references

David J Canty

series ordinal

2

0 references

Ridwan Shabsigh

series ordinal

3

0 references

language of work or name

English

0 references

publication date

September 2008

0 references

published in

Postgraduate Medicine

0 references

volume

120

0 references

issue

3

0 references

page(s)

130-53

0 references

1 reference

Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Differential anabolic effects of testosterone and amino acid feeding in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of an oral androgen on muscle and metabolism in older, community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Endogenous testosterone levels, physical performance, and fall risk in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone treatment for men with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Androgen treatment of abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Cardiovascular issues in hypogonadism and testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone therapy in erectile dysfunction and hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone supplementation improves spatial and verbal memory in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone influences spatial cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Androgen and progestagen effects on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914

Testosterone in older men after the Institute of Medicine Report: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1914